662: HER2 isoforms in mammary carcinogenesis and targeted therapy susceptibility
Palladini, A, Dall’Ora, M, Grosso, V, Ianzano, M.L, Ranieri, D, Balboni, T, Iezzi, M, De Giovanni, C, Lollini, P.L, Nanni, P
Published in European journal of cancer (1990) (01.07.2014)
Published in European journal of cancer (1990) (01.07.2014)
Get full text
Journal Article
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), through an innovative virus-like particles (VLP)-based vaccine, enhance the antitumoral activity of a HER-2-VLP vaccine in a preclinical model of HER-2 positive breast cancer
Ruzzi, F., Scalambra, L., Semprini, M.S., Pittino, O.M., Cappello, C., Angelicola, S., Palladini, A., Nanni, P., Fougeroux, C., Goksøyr, L., Sander, A.F., Lollini, P.L.
Published in European journal of cancer (1990) (01.03.2024)
Published in European journal of cancer (1990) (01.03.2024)
Get full text
Journal Article
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer
Pantaleo, M. A., Nannini, M., Maleddu, A., Fanti, S., Nanni, C., Boschi, S., Lodi, F., Nicoletti, G., Landuzzi, L., Lollini, P. L., Biasco, G.
Published in Annals of oncology (01.02.2009)
Published in Annals of oncology (01.02.2009)
Get full text
Journal Article